Michael Matson
Stock Analyst at Needham
(2.21)
# 2,796
Out of 5,154 analysts
25
Total ratings
60%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $113.31 | +273.31% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $6.47 | +1,291.04% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $72.66 | -27.06% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $87.10 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $252.87 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $71.35 | - | 1 | Dec 8, 2017 | |
| KTWO K2 Capital Acquisition | Downgrades: Buy | n/a | $10.05 | - | 2 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $63.84 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $364.56 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $8.01 | - | 1 | Mar 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $75.74 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $80.00 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.24 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.62 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $527.33 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $113.31
Upside: +273.31%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.47
Upside: +1,291.04%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $72.66
Upside: -27.06%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $87.10
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $252.87
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $71.35
Upside: -
K2 Capital Acquisition
Dec 8, 2017
Downgrades: Buy
Price Target: n/a
Current: $10.05
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $63.84
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $364.56
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $8.01
Upside: -
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $75.74
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $80.00
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.24
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $4.62
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $527.33
Upside: -